Chaperonology: The Third Eye on Brain Gliomas

Area of Science:

• Neuro-oncology
• Neurosurgery
• Molecular Biology

Background:

• The standard treatment for high-grade gliomas (HGG) involves maximal safe surgical resection, radiotherapy, and concurrent temozolamide.
• Balancing maximal tumor removal with neurological function preservation is critical for HGG patients.
• Despite poor prognosis, advancements in molecular and genetic research offer new therapeutic avenues for HGG.

Purpose of the Study:

• To provide a comprehensive overview of current pre-operative, intra-operative, and molecular approaches for HGG management.
• To highlight the role of heat shock proteins (Hsps) as potential biomarkers and therapeutic targets in HGG.

Main Methods:

• Review of current pre-operative techniques, including advanced neuro-imaging.
• Analysis of intra-operative strategies, such as neuro-monitoring.
• Exploration of molecular and genetic advancements, focusing on heat shock proteins (Hsps).

Main Results:

• Neuro-imaging and neuro-monitoring have improved survival rates and quality of life for HGG patients.
• Molecular and genetic research presents novel frontiers for HGG management.
• Heat shock proteins (Hsps) show promise as biomarkers for HGG detection and monitoring, and potentially as therapeutic agents.

Conclusions:

• Current HGG management integrates surgical, radiological, and chemotherapeutic approaches.
• Emerging molecular strategies, particularly those involving Hsps, offer potential for improved HGG diagnosis and treatment.
• Continued research into HGG's molecular landscape is crucial for developing more effective therapies.